It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...

Only 23 countries use climate data for health surveillance, says head of WMO, adding more collaboration needed ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...

Claims of QuantumScape’s ex-CEO Jagdeep Singh earning Rs 48 crore daily are false, as verified through official documents and company statements. Pravrajya Suruchi Updated : Jan 10, 2025, 12:00 AM IST ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.